BCDA

BioCardia, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Altman PeterDirector, Officer: President And CEO
$1.3k1.5k shares
BuyJun 17, 2026
$0.85
$0.9668
Altman PeterDirector, Officer: President And CEO
$768800 shares
BuyJun 18, 2026
$0.96
$0.9668
Gillis Edward MSenior Vice President, Devices
$6.5k3.3k shares
SellDec 20, 2024
$2.00
--
Altman PeterDirector, Officer: President And CEO
$1.5k600 shares
BuyFeb 7, 2025
$2.48
--
Altman PeterDirector, Officer: President And CEO
$1.1k500 shares
BuyMar 3, 2025
$2.11
--
Stertzer Simon HDirector
$52k22.8k shares
BuyMar 3, 2025
$2.30
--

News

globenewswire.comBioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunitiesglobenewswire.comJun 18globenewswire.comBioCardia Announces $4.4 Million Financingglobenewswire.comJun 8benzinga.comWhy Is BioCardia Stock Gaining Friday?benzinga.comJun 5globenewswire.comFDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEFglobenewswire.comJun 5globenewswire.comBioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequencyglobenewswire.comMay 21